UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:January 17,
Boundless Bio (NASDAQ:BOLD)
Historical Stock Chart
From Nov 2024 to Dec 2024 Click Here for more Boundless Bio Charts.
Boundless Bio (NASDAQ:BOLD)
Historical Stock Chart
From Dec 2023 to Dec 2024 Click Here for more Boundless Bio Charts.

Audentes Therapeutics, Inc. News

Boundless Bio to Participate in the Piper Sandler Healthcare Conference
Monday 25 November 2024 (1 week ago) • GlobeNewswire Inc.
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (4 weeks ago) • Edgar (US Regulatory)
Form 8-K - Current report
Friday 8 November 2024 (4 weeks ago) • Edgar (US Regulatory)
Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights
Friday 8 November 2024 (4 weeks ago) • GlobeNewswire Inc.
Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference
Tuesday 5 November 2024 (4 weeks ago) • GlobeNewswire Inc.
Form 8-K - Current report
Tuesday 15 October 2024 (2 months ago) • Edgar (US Regulatory)
Boundless Bio Announces Departure of Chief Financial Officer
Monday 14 October 2024 (2 months ago) • GlobeNewswire Inc.
Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference
Wednesday 11 September 2024 (3 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 21 August 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 21 August 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 13 August 2024 (4 months ago) • Edgar (US Regulatory)
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Tuesday 13 August 2024 (4 months ago) • Edgar (US Regulatory)

More Audentes Therapeutics, Inc. News Articles

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36